BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7382187)

  • 81. [Contribution to diagnostic radiology of tumors of the adrenal glands (author's transl)].
    Deininger HK; Heuck F; Hiness R
    Radiologe; 1975 Jul; 15(7):269-77. PubMed ID: 1197713
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Diagnostic possibilities of scintigraphy with radiocholesterol (author's transl)].
    Troncone L; Salvo D; Barbarino A; Marano P; Galli G
    Radiol Med; 1976 Dec; 62(12):965-80. PubMed ID: 1027051
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Synthesis of radioiodinated metyrapone--a potential adrenal imaging agent.
    Robien W; Zolle I
    Int J Appl Radiat Isot; 1983 Jun; 34(6):907-14. PubMed ID: 6874117
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Adverse reactions following NP-59 administration.
    Spyridonidis T; Giannakenas C; Lakiotis V; Apostolopoulos DJ
    Nucl Med Commun; 2008 Aug; 29(8):749-50. PubMed ID: 18753831
    [No Abstract]   [Full Text] [Related]  

  • 85. Selenium 75 selenomethyl cholesterol: a new agent for quantitative functional scintigraphy of the adrenals: physical aspects.
    Hawkins LA; Britton KE; Shapiro B
    Br J Radiol; 1980 Sep; 53(633):883-9. PubMed ID: 7437711
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical significance of the solitary functioning adrenal gland.
    Gross MD; Shapiro B; Freitas JE; Meyers L; Francis I; Thompson NW; Wortsman J
    J Nucl Med; 1991 Oct; 32(10):1882-7. PubMed ID: 1919725
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Scintigraphic studies of the adrenal and parathyroid glands].
    Taillefer R; Picard D; Levasseur A
    Union Med Can; 1986 Apr; 115(4):243-7. PubMed ID: 3521037
    [No Abstract]   [Full Text] [Related]  

  • 88. [Assessment of diagnostic possibilities of adrenal phlebography (author's transl)].
    Pruszyński B; Januszewicz W; Rajszys R; Feltyński T; Jagielski J; Szostek M
    Pol Przegl Radiol Med Nukl; 1979; 43(6):431-6. PubMed ID: 547269
    [No Abstract]   [Full Text] [Related]  

  • 89. [Indication criteria for radiologic demonstration of adrenal glands].
    Goischke HK
    Dtsch Med Wochenschr; 1977 Nov; 102(44):1614-5. PubMed ID: 923438
    [No Abstract]   [Full Text] [Related]  

  • 90. Positive imaging of arrhenoblastoma of the ovary with 131I-Adosterol: case report.
    Nakajo M; Sakata H; Shinohara S
    Radioisotopes; 1978 Jul; 27(7):407-9. PubMed ID: 212791
    [No Abstract]   [Full Text] [Related]  

  • 91. Scintigraphic imaging of the adrenal glands.
    Kurtaran A; Traub T; Shapiro B
    Eur J Radiol; 2002 Feb; 41(2):123-30. PubMed ID: 11809541
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Scintigraphy of hyperfunctioning adrenal tissue after total adrenalectomy.
    Jakubowski W; Graban W
    Eur J Nucl Med; 1978; 3(4):239-41. PubMed ID: 720354
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Ga-67 and I-131 adosterol scintigraphic findings of bilateral primary adrenal lymphoma.
    Suga K; Ishikawa Y; Matsunaga N; Motoyama K; Hara A
    Clin Nucl Med; 2000 Sep; 25(9):718-20. PubMed ID: 10983762
    [No Abstract]   [Full Text] [Related]  

  • 94. A comparison of 19-iodocholesterol-131I with 6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol-131I as an adrenal-scanning agent.
    Nitta K; Ogawa H; Ito T; Kojima M; Maeda M
    Chem Pharm Bull (Tokyo); 1976 Oct; 24(10):2322-6. PubMed ID: 1017078
    [No Abstract]   [Full Text] [Related]  

  • 95. Adrenal imaging agents: rationale, synthesis, formulation and, metabolism.
    Beierwaltes WH; Wieland DM; Yu T; Swanson DP; Mosley ST
    Semin Nucl Med; 1978 Jan; 8(1):5-21. PubMed ID: 635596
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Transport of circulating serum cholesterol by human renal cell carcinoma.
    Clayman RV; Figenshau RS; Prigge WF; Forstrom L; Gebhard RL
    J Urol; 1987 Jun; 137(6):1262-5. PubMed ID: 3586171
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Synthesis of 6 beta-[131I](2'-iodo)ethyl-19-norcholest-5(10)-en-3 beta-ol and its tissue distribution in mice.
    Kojima M; Maeda M; Kobayashi T; Liu BL; Jin YT; Li TH; Tang ZG
    Chem Pharm Bull (Tokyo); 1987 May; 35(5):2101-3. PubMed ID: 3664814
    [No Abstract]   [Full Text] [Related]  

  • 98. Visualization of adrenocortical carcinoma lung metastases with iodine-131 labeled 6B-iodomethylnorcholesterol (NP-59).
    Chow CK; Ziessman HA; Earll JM
    Clin Nucl Med; 1987 Jun; 12(6):468-70. PubMed ID: 3595030
    [TBL] [Abstract][Full Text] [Related]  

  • 99. NCL-6-124I: a PET agent for the adrenal.
    Somawardhana CW; Amartey JK; Kojima M; Lambrecht RM
    Int J Rad Appl Instrum A; 1990; 41(12):1223-4. PubMed ID: 1963422
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Evaluation of adrenal diseases with a new adrenal-scanning agent, 6-methyl-75Se-selenomethyl-19-norcholest-5(10)-en-3 beta-ol (author's transl)].
    Seto H; Futatsuya R; Kakishita M; Mori H; Hisada K
    Radioisotopes; 1980 May; 29(5):247-9. PubMed ID: 7414016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.